Annual CFF:
$348.00K-$3.19M(-90.18%)Summary
- As of today, AMLX annual cash from financing is $348.00 thousand, with the most recent change of -$3.19 million (-90.18%) on December 31, 2024.
- During the last 3 years, AMLX annual cash from financing has fallen by -$158.16 million (-99.78%).
- AMLX annual cash from financing is now -99.92% below its all-time high of $431.79 million, reached on December 31, 2022.
Performance
AMLX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$191.61M+$191.64M(+618183.87%)Summary
- As of today, AMLX quarterly cash from financing is $191.61 million, with the most recent change of +$191.64 million (+618183.87%) on September 30, 2025.
- Over the past year, AMLX quarterly cash from financing has increased by +$191.53 million (+239407.50%).
- AMLX quarterly cash from financing is now -17.47% below its all-time high of $232.16 million, reached on December 31, 2022.
Performance
AMLX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$257.35M+$191.53M(+290.98%)Summary
- As of today, AMLX TTM cash from financing is $257.35 million, with the most recent change of +$191.53 million (+290.98%) on September 30, 2025.
- Over the past year, AMLX TTM cash from financing has increased by +$256.88 million (+54888.68%).
- AMLX TTM cash from financing is now -40.40% below its all-time high of $431.79 million, reached on December 31, 2022.
Performance
AMLX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMLX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -90.2% | +10000.0% | +10000.0% |
| 3Y3 Years | -99.8% | +100.0% | +28.9% |
| 5Y5 Years | -47.9% | - | - |
AMLX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -99.9% | at low | -17.5% | >+9999.0% | -40.4% | >+9999.0% |
| 5Y | 5-Year | -99.9% | at low | -17.5% | >+9999.0% | -40.4% | >+9999.0% |
| All-Time | All-Time | -99.9% | at low | -17.5% | >+9999.0% | -40.4% | >+9999.0% |
AMLX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $191.61M(>+9900.0%) | $257.35M(+291.0%) |
| Jun 2025 | - | -$31.00K(-100.0%) | $65.82M(-0.1%) |
| Mar 2025 | - | $65.66M(>+9900.0%) | $65.88M(>+9900.0%) |
| Dec 2024 | $348.00K(-90.2%) | $110.00K(+37.5%) | $348.00K(-25.6%) |
| Sep 2024 | - | $80.00K(+196.3%) | $468.00K(-63.4%) |
| Jun 2024 | - | $27.00K(-79.4%) | $1.28M(-51.5%) |
| Mar 2024 | - | $131.00K(-43.0%) | $2.63M(-25.7%) |
| Dec 2023 | $3.54M | $230.00K(-74.1%) | $3.54M(-98.5%) |
| Sep 2023 | - | $889.00K(-35.8%) | $235.47M(+0.4%) |
| Jun 2023 | - | $1.38M(+33.1%) | $234.59M(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $1.04M(-99.6%) | $232.37M(-46.2%) |
| Dec 2022 | $431.79M(+172.4%) | $232.16M(>+9900.0%) | $431.79M(+116.3%) |
| Sep 2022 | - | $0.00(+100.0%) | $199.63M(0.0%) |
| Jun 2022 | - | -$828.00K(-100.4%) | $199.63M(-1.4%) |
| Mar 2022 | - | $200.46M(>+9900.0%) | $202.45M(+625.1%) |
| Dec 2021 | $158.51M(+238.5%) | - | - |
| Jun 2021 | - | $1.99M(-92.3%) | $27.92M(+7.7%) |
| Mar 2021 | - | $25.93M | $25.93M |
| Dec 2020 | $46.82M(+6909.4%) | - | - |
| Dec 2019 | $668.00K | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual cash from financing year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual cash from financing?
The current annual cash from financing of AMLX is $348.00K
What is the all-time high annual cash from financing for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual cash from financing is $431.79M
What is Amylyx Pharmaceuticals, Inc. annual cash from financing year-on-year change?
Over the past year, AMLX annual cash from financing has changed by -$3.19M (-90.18%)
What is Amylyx Pharmaceuticals, Inc. quarterly cash from financing?
The current quarterly cash from financing of AMLX is $191.61M
What is the all-time high quarterly cash from financing for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly cash from financing is $232.16M
What is Amylyx Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
Over the past year, AMLX quarterly cash from financing has changed by +$191.53M (+239407.50%)
What is Amylyx Pharmaceuticals, Inc. TTM cash from financing?
The current TTM cash from financing of AMLX is $257.35M
What is the all-time high TTM cash from financing for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM cash from financing is $431.79M
What is Amylyx Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
Over the past year, AMLX TTM cash from financing has changed by +$256.88M (+54888.68%)